IPO - Bon Natural Life Ltd

Form Type: 424B4

Filing Date: 2025-03-18

Corporate Action: Ipo

Type: New

Accession Number: 000149315225010708

Filing Summary: Bon Natural Life Limited is offering up to 8,333,332 units, each containing one Class A ordinary share, one Series A warrant, and one Series B warrant at a public offering price of $1.44 per unit. Additionally, the company is offering up to 8,333,332 pre-funded units containing one pre-funded warrant, one Series A warrant, and one Series B warrant. A total of 124,999,980 Class A ordinary shares underlying the warrants are being registered. For large purchasers who would exceed 4.99% or 9.99% ownership after the offering, pre-funded warrants can be purchased in place of additional shares. The Series A and Series B warrants will be immediately exercisable, with Series A warrants resetting their exercise price based on average trading prices after 30 days. The exercise of Series B warrants may occur through a zero exercise price option. The offering strategy is planned on a best-efforts basis and the shares are intended to be listed on Nasdaq.

Document Link: View Document

Form Type: CORRESP

Filing Date: 2025-03-14

Corporate Action: Ipo

Type: New

Accession Number: 000149315225010307

Filing Summary: Bon Natural Life Limited has filed a request for acceleration of the effective date of its Registration Statement on Form F-1, allowing it to become effective as of 5:00 p.m. Eastern Time on March 14, 2025. This request is made pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, with Univest Securities, LLC acting as the placement agent. The document outlines the compliance with the requirements under the Securities Exchange Act of 1934.

Document Link: View Document

Form Type: F-1/A

Filing Date: 2025-03-13

Corporate Action: Ipo

Type: Update

Accession Number: 000149315225010155

Filing Summary: This document is an amendment to the Form F-1 registration statement for Bon Natural Life Limited. The company is offering up to 10 million units, each consisting of one Class A ordinary share, with associated warrants (Series A and Series B). Additionally, the company is offering up to 10 million pre-funded units, similar in structure to the ordinary units. The document details the structure of the offering, the target number of shares to be offered, and the various types of warrants that will be available. The anticipated public offering price is projected to be $1.20 per unit. As an emerging growth company, Bon Natural Life Limited continues to progress its public offering as necessary files with the SEC, indicating they may delay effectiveness until future amendments explicitly state the registration will become effective.

Document Link: View Document

Form Type: CORRESP

Filing Date: 2025-03-03

Corporate Action: Ipo

Type: Update

Accession Number: 000149315225008883

Filing Summary: On March 3, 2025, Bon Natural Life Ltd submitted Amendment No. 3 to its Registration Statement on Form F-1, addressing comments from the SEC's staff dated February 24, 2025, which was in response to Amendment No. 2 filed on February 18, 2025. The letter outlines necessary revisions to the cover page of the registration statement to reflect the registration of an additional 5,000,000 Class A Ordinary Shares alongside the existing shares underlying the Pre-Funded Warrants and the Series A and B Warrants. Further details include a clarification regarding the Series A and Series B warrants, which feature cashless exercise options, potentially increasing the total number of shares issued upon exercise. The correspondence reassures that these revisions are made in compliance with the SEC's requests and highlights that cash proceeds from warrant exercises may be minimal due to the attractiveness of the cashless exercise option for warrant holders.

Document Link: View Document

Form Type: F-1/A

Filing Date: 2025-03-03

Corporate Action: Ipo

Type: New

Accession Number: 000149315225008880

Filing Summary: Bon Natural Life Ltd is filing an Amendment No. 3 to their registration statement, Form F-1, for the proposed sale of ordinary shares and associated warrants. The company is offering up to 10,000,000 Ordinary Units, each comprising a Class A ordinary share, a Series A warrant, and a Series B warrant. Additionally, they plan to offer up to 10,000,000 Pre-Funded Units which include a pre-funded warrant alongside the Series A and B warrants. The maximum offer price is set at $1.20 per Unit. This IPO is being conducted on a best-efforts basis, and they are also registering up to 150,000,000 Class A Ordinary Shares underlying these warrants. The offering will commence as soon as practicable after the registration statement is declared effective by the SEC.

Document Link: View Document

Form Type: CORRESP

Filing Date: 2025-02-18

Corporate Action: Ipo

Type: Update

Accession Number: 000149315225007210

Filing Summary: Bon Natural Life Ltd is filing Amendment No. 2 to its Registration Statement on Form F-1, addressing comments from the SEC regarding Amendment No. 1 submitted on January 16, 2025. The amendment clarifies the offering of up to 15,000,000 Class A Ordinary Shares, including shares from Pre-Funded Warrants and Series A and B Warrants, specifying that not all shares depend on warrant exercises. The offering may be extended by mutual agreement with the placement agent, and a specific termination date for the offering was added in response to SEC guidelines. The correspondence is to various SEC officials for further assistance and clarification regarding their earlier comments.

Document Link: View Document

Form Type: CORRESP

Filing Date: 2025-01-16

Corporate Action: Ipo

Type: Update

Accession Number: 000149315225002617

Filing Summary: Bon Natural Life Ltd, a Cayman Islands exempted company, filed an amendment to its Registration Statement on Form F-1 on January 16, 2025, after addressing comments made by the SEC staff on November 26, 2024. This amendment revises key sections requested by the SEC, such as quantifying the number of Ordinary Shares being registered and disclosing the markets for its securities since they began trading on the Nasdaq Capital Market under the ticker symbol 'BON' on June 24, 2021. Additionally, the company has updated the Management Compensation section to include details on the compensation of executive officers and directors for the most recently completed financial year.

Document Link: View Document